The MarketWatch News Department was not involved in the creation of this content. Amber Implants Appoints Vincent Gardès as Chief Executive Officer to Drive Commercial Launch of VCFix(R) Spinal System ...
Experienced MedTech leader to guide Amber Implants' transition from development into commercialization following FDA clearance of the VCFix® Spinal System Company preparing for U.S. market launch in ...
THE HAGUE, The Netherlands, Nov. 6, 2025 /PRNewswire/ -- Amber Implants, an innovative medical technology company developing next-generation implants for spinal injuries, today announced the ...
· Experienced MedTech leader to guide Amber Implants’ transition from development into commercialization following FDA clearance of the VCFix® Spinal System The Hague, The Netherlands, 6 November 2025 ...
With 30 years of international leadership experience in the MedTech sector across Europe and the U.S., Vincent brings deep expertise in commercial strategy, market expansion, and value creation. He ...
SEALSQ Corp (Nasdaq: LAES), ("SEALSQ" or "Company"), a global leader in cybersecurity, semiconductor technology and post-quantum security solutions, today announce that, following the June 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback